Repligen Corporation (RGEN) Revenue Growth
Repligen Corporation (RGEN) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 35.10% |
| 2018-12-31 | 37.38% |
| 2019-12-31 | 39.28% |
| 2020-12-31 | 35.53% |
| 2021-12-31 | 83.08% |
| 2022-12-31 | 19.54% |
| 2023-12-31 | -21.11% |
| 2024-12-31 | 0.33% |
| 2025-12-31 | 16.36% |
How RGEN compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| PEN | Penumbra Inc. | 17.50% |
| ATRC | AtriCure Inc. | 14.88% |
| MMSI | Merit Medical Systems Inc. | 11.75% |
| EW | Edwards Lifesciences Corporation | 11.55% |
| NEO | NeoGenomics Inc. | 10.11% |
These are five companies in the same sector as RGEN with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Repligen Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("RGEN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RGEN | $174.44 | +2.60% | 0.48M |
| 3 | ||||
| 4 | ||||
| 5 |